id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2008-0749-0004,EPA,EPA-HQ-OPP-2008-0749,Draft Rule -Trichoderma gamsii strain ICC 080 Tolerance Exemption,Other,,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,2010-01-30T04:59:59Z,2009-12-31T17:10:27Z,,0,0,0900006480a71750
EPA-HQ-OPP-2008-0750-0004,EPA,EPA-HQ-OPP-2008-0750,Draft Rule- Trichoderma asperellum strain ICC 012; Tolerance Exemption,Other,,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,2010-01-30T04:59:59Z,2009-12-31T17:12:22Z,,0,0,0900006480a71754
FDA-2009-P-0272-0003,FDA,FDA-2009-P-0272,"FDA/CDER Response to Sanofi-aventis, U.S., LLC - Petition Partial Approval and Denial",Other,PPAD-Petition Partial Approval and Denial,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2013-07-27T23:02:09Z,,0,0,0900006480a68fe7
FDA-1995-S-0036-0109,FDA,FDA-1995-S-0036,"Report 38 - Baylor College of Medicine Public Disclosure on IND 100,681",Other,RPT-Report,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2013-07-27T23:02:32Z,,0,0,0900006480a6b5ec
FDA-2009-P-0598-0001,FDA,FDA-2009-P-0598,James Matthew Weber - Citizen Petition,Other,CP-Citizen Petition,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2012-03-06T19:35:08Z,,0,0,0900006480a74a4d
FDA-2009-P-0298-0007,FDA,FDA-2009-P-0298,"FDA/CFSAN Interim Response to OVOS Natural Health, Inc. (Ullman, Shapiro & Ullman, LLP) - Letter",Other,LET-Letter,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2013-08-11T04:36:59Z,,0,0,0900006480a69fe6
FDA-2009-P-0598-0002,FDA,FDA-2009-P-0598,Acknowledgement Letter to James Matthew Weber,Other,ACK-Acknowledgement Letter,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2013-08-11T01:31:47Z,,0,0,0900006480a74a4e
FDA-2008-D-0525-0013,FDA,FDA-2008-D-0525,New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products:  Guidance for Industry,Other,Guidance,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2024-11-07T22:12:12Z,,1,0,0900006480a77652
EPA-HQ-OPP-2009-1004-0002,EPA,EPA-HQ-OPP-2009-1004,Trichoderma Asperellum Strain ICC 0112,Other,NA,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,2010-01-30T04:59:59Z,2010-08-27T14:40:53Z,,0,0,0900006480a73f69
EPA-HQ-OPP-2009-1003-0002,EPA,EPA-HQ-OPP-2009-1003,Trichoderma Gamsii Strain ICC 080,Other,NA,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,2010-01-30T04:59:59Z,2010-08-27T14:50:23Z,,0,0,0900006480a73f9a
EPA-HQ-SFUND-2009-1002-0001,EPA,EPA-HQ-SFUND-2009-1002,"Memorandum to the Docket from Lois Gartner, USEPA/OSWER/Community Involvement and Program Initiatives Branch through Elizabeth Southerland, Director, USEPA/OSWER/Assessment and Remediation Division",Other,,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,,2010-06-16T14:22:05Z,,0,0,0900006480a72fd3
FDA-2009-P-0282-0003,FDA,FDA-2009-P-0282,"FDA/CDRH to Mr. David S. Smith (Pepper Hamilton, LLP)",Other,LET-Letter,2009-12-30T05:00:00Z,2009,12,2009-12-30T05:00:00Z,,2013-07-27T23:03:28Z,,0,0,0900006480a7444f
EPA-HQ-RCRA-2009-0315-0259,EPA,EPA-HQ-RCRA-2009-0315,"Memorandum to Docket from Kathy Lett, USEPA/OSWER/ORCR/MRWMD through Robert Dellinger, Division Director, USEPA/OSWER/ORCR/MRWMD",Other,,2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,2010-03-16T03:59:59Z,2010-06-16T14:23:34Z,,0,0,0900006480a736e8
FDA-2009-P-0597-0031,FDA,FDA-2009-P-0597,Acknowledgement Letter to GlaxoSmithKline,Other,ACK-Acknowledgement Letter,2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,,2013-08-11T03:05:59Z,,0,0,0900006480a6dd07
FDA-2009-D-0591-0002,FDA,FDA-2009-D-0591,Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions,Other,GDL-Guidance (Supporting and Related Materials),2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,,2024-11-07T22:11:11Z,,1,0,0900006480a73756
FDA-2009-P-0597-0001,FDA,FDA-2009-P-0597,GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition,Other,CP-Citizen Petition,2009-12-29T05:00:00Z,2009,12,2009-12-29T05:00:00Z,,2019-01-30T20:17:16Z,,0,0,0900006480a6c85b
FDA-1996-P-0383-0001,FDA,FDA-1996-P-0383,Fuisz Technologies Ltd - Citizen Petition,Other,CP-Citizen Petition,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2009-12-28T20:30:15Z,,0,0,0900006480506ffd
FDA-1996-P-0383-0002,FDA,FDA-1996-P-0383,Fuisz Technologies Ltd - Letter,Other,LET-Letter,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2009-12-28T20:30:17Z,,0,0,0900006480507008
FDA-1984-P-0333-0001,FDA,FDA-1984-P-0333,Petition Approval from Center for Drugs and Biologics to Sterling Drug Inc,Other,Approval,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2022-05-17T20:03:37Z,,0,0,09000064805a9401
FDA-1996-P-0383-0004,FDA,FDA-1996-P-0383,Acknowledgement Letter to Fuisz Technologies LTD,Other,ACK-Acknowledgement Letter,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2009-12-28T20:30:21Z,,0,0,0900006480a72ac2
FDA-1996-P-0383-0003,FDA,FDA-1996-P-0383,Fuisz Technologies Ltd. - Withdrawal,Other,CP-Citizen Petition,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2013-07-27T21:20:27Z,,0,0,090000648050700a
FDA-1984-P-0333-0002,FDA,FDA-1984-P-0333,Acknowledgement Letter from Dockets Management Branch to Sterling Drug Inc,Other,Acknowledgement Letter/Receipt,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2022-05-18T15:15:25Z,,0,0,0900006480a72b74
FDA-2009-D-0600-0002,FDA,FDA-2009-D-0600,Draft Guidance for Industry on Tobacco Health Document Submission - Guidance,Other,Guidance,2009-12-28T05:00:00Z,2009,12,2009-12-28T05:00:00Z,,2024-11-07T22:13:38Z,,1,0,0900006480a71ffb
FDA-2009-P-0297-0003,FDA,FDA-2009-P-0297,AllerQuest LLC to FDA - Withdrawal of Petition,Other,WDL-Withdrawal,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2013-07-27T23:03:06Z,,0,0,0900006480a7087b
FDA-2002-D-0223-0003,FDA,FDA-2002-D-0223,An Acceptable Circular of Information for the Use of Human Blood and Blood Components - Level 2 Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2024-11-07T22:12:43Z,,1,0,0900006480a700ff
FDA-2009-P-0305-0001,FDA,FDA-2009-P-0305,Hygeia II Medical Group Inc. - Citizen Petition,Other,CP-Citizen Petition,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2020-05-05T14:43:19Z,,0,0,09000064809e79c6
FDA-2009-P-0305-0002,FDA,FDA-2009-P-0305,Acknowledgement Letter to Hygeia II Medical Group Inc.,Other,ACK-Acknowledgement Letter,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2009-12-23T15:29:49Z,,0,0,09000064809e79c9
FDA-1987-P-0230-0002,FDA,FDA-1987-P-0230,FDA/Center for Drugs and Biologics - Petition Approval,Other,PAV-Petition Approval,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2013-07-27T20:47:57Z,,0,0,090000648046d7d3
FDA-2009-P-0305-0003,FDA,FDA-2009-P-0305,FDA/Center for Devices and Radiological Health Interim Response to  Hygeia II Medical Group Inc.,Other,LET-Letter,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2013-08-11T01:31:35Z,,0,0,0900006480a6b1c4
FDA-1987-P-0230-0003,FDA,FDA-1987-P-0230,Acknowledgement Letter to Sidmak Laboratories Inc,Other,ACK-Acknowledgement Letter,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2009-12-23T17:23:52Z,,0,0,0900006480a707a1
FDA-2008-D-0399-0007,FDA,FDA-2008-D-0399,"Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions, Annex 5 Disintegration Test General Chapter - Guidance for Industry",Other,GDL-Guidance (Supporting and Related Materials),2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2024-11-12T04:49:00Z,,1,0,0900006480a70857
FDA-1987-P-0230-0001,FDA,FDA-1987-P-0230,"Sidmak Laboratories, Inc - Citizen Petition",Other,CP-Citizen Petition,2009-12-23T05:00:00Z,2009,12,2009-12-23T05:00:00Z,,2013-07-27T20:47:57Z,,0,0,090000648046d7d2
EPA-HQ-OPP-2009-0044-0002,EPA,EPA-HQ-OPP-2009-0044,Lavandulyl Senecioate Bipesticides,Other,NA,2009-12-22T05:00:00Z,2009,12,2009-12-22T05:00:00Z,2010-01-21T04:59:59Z,2010-08-27T15:31:32Z,,0,0,0900006480a6f8f2
FDA-2009-D-0588-0002,FDA,FDA-2009-D-0588,Guidance for Industry on the Timeframe for Submission of Tobacco Health Documents - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-22T05:00:00Z,2009,12,2009-12-22T05:00:00Z,,2024-11-07T22:11:18Z,,1,0,0900006480a6f5bc
FDA-2009-D-0013-0005,FDA,FDA-2009-D-0013,International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-22T05:00:00Z,2009,12,,,2024-11-07T22:13:57Z,,1,0,0900006480a6f8f1
FDA-2009-P-0405-0021,FDA,FDA-2009-P-0405,"Consumers Union and Food Animal Concerns Trust (FACT) [Multiple Names=37,170 Citizens] - Letter",Other,LET-Letter,2009-12-18T05:00:00Z,2009,12,2009-12-18T05:00:00Z,,2010-01-05T22:42:57Z,,0,0,0900006480a6e1f4
FDA-2003-M-0501-0003,FDA,FDA-2003-M-0501,DUPLICATE,Other,AAV-Approval of Application,2009-12-18T05:00:00Z,2009,12,2009-12-18T05:00:00Z,,2025-04-01T19:30:11Z,,0,0,09000064804a2b21
FDA-2003-M-0501-0002,FDA,FDA-2003-M-0501,"Premarket Approval Response Letter from FDA CDRH to Boston Scientific Scimed, Inc.",Other,Approval,2009-12-18T05:00:00Z,2009,12,2009-12-18T05:00:00Z,,2025-04-01T19:34:05Z,,0,0,09000064804a2b1f
FDA-2003-M-0501-0004,FDA,FDA-2003-M-0501,"Background Materials re: Premarket Approval Response Letter from FDA CDRH to Boston Scientific Scimed, Inc.",Other,Background Material,2009-12-18T05:00:00Z,2009,12,2009-12-18T05:00:00Z,,2025-04-01T19:36:00Z,,0,0,09000064804a2b22
EPA-HQ-OEI-2009-0453-0001,EPA,EPA-HQ-OEI-2009-0453,Docket EPA-HQ-OEI-2009-0453 Open for Public Access,Other,,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2010-07-15T19:27:50Z,,0,0,0900006480a6c417
FDA-2003-P-0127-0004,FDA,FDA-2003-P-0127,"The Weinberg Group, Inc.  - Petition Withdrawal re FDA-2003-P-0127-0003",Other,WDL-Withdrawal,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2024-10-30T20:35:50Z,,0,0,0900006480a6b578
FDA-2009-D-0574-0002,FDA,FDA-2009-D-0574,Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T20:39:09Z,,0,0,0900006480a6d53a
FDA-2003-P-0127-0003,FDA,FDA-2003-P-0127,"Citizen Petition from The Weinberg Group, Inc.",Other,CP-Citizen Petition,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2024-10-30T20:56:47Z,,0,0,0900006480486267
FDA-2009-P-0567-0003,FDA,FDA-2009-P-0567,Arent Fox LLP - Withdrawal,Other,WDL-Withdrawal,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2013-07-27T23:02:39Z,,0,0,0900006480a6ba1b
FDA-2009-P-0273-0004,FDA,FDA-2009-P-0273,"FDA/CDER Interim Response to Lachman Consultant Services, Inc. - Letter",Other,LET-Letter,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2013-07-27T23:02:16Z,,0,0,0900006480a69fe3
FDA-2009-P-0595-0002,FDA,FDA-2009-P-0595,Acknowledgement Letter to Public Citizen Health Research Group,Other,ACK-Acknowledgement Letter,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2009-12-17T23:10:44Z,,0,0,0900006480a6b5a8
FDA-2009-D-0573-0002,FDA,FDA-2009-D-0573,Addendum To ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1) - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-02T04:59:59Z,2023-12-21T02:00:44Z,,0,0,0900006480a6d52c
FDA-2009-P-0595-0001,FDA,FDA-2009-P-0595,Public Citizen Health Research Group - Citizen Petition,Other,CP-Citizen Petition,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,,2011-01-05T16:57:05Z,,0,0,0900006480a6b5a7
FDA-2009-D-0579-0002,FDA,FDA-2009-D-0579,Q4B Evaluation and Recommenations of Pharmacopoeial Texts for Use in the ICH Regions - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T19:31:20Z,,0,0,0900006480a6cf78
FDA-2009-P-0593-0001,FDA,FDA-2009-P-0593,Grove Medical LLC - Citizen Petition,Other,,2009-12-17T00:00:00Z,2009,12,,,2013-08-11T03:05:56Z,,0,1,0900006480a6b102
FDA-2009-P-0593-0002,FDA,FDA-2009-P-0593,Acknowledgement Letter to Grove Medical LLC,Other,,2009-12-17T00:00:00Z,2009,12,,,2013-08-11T03:05:56Z,,0,1,0900006480a6b103
APHIS-2007-0044-0253,APHIS,APHIS-2007-0044,Glyphosate-Tolerant Alfalfa Events J101 and J163: Request for Nonregulated Status -- Draft Environmental Impact Statement(November 2009),Other,EIS,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,2010-03-04T04:59:59Z,2010-02-18T12:39:37Z,,0,0,0900006480a6b7a1
FDA-2009-P-0589-0001,FDA,FDA-2009-P-0589,Buchanan Ingersoll & Rooney PC - Citizen Petition,Other,CP-Citizen Petition,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2012-03-09T16:55:44Z,,0,0,0900006480a62246
FDA-1975-N-0013-0025,FDA,FDA-1975-N-0013,"Request for Hearing from Alcavis International, Inc. (Buchanan, Ingersoll & Rooney, PC)",Other,Request for Hearing,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2017-11-13T19:00:29Z,,0,0,0900006480a4e166
FDA-2009-P-0185-0003,FDA,FDA-2009-P-0185,"Bioniche Pharma, LLC - Amendment",Other,AMD-Amendment,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2013-07-27T23:01:53Z,,0,0,0900006480a6714d
FDA-1975-N-0013-0024,FDA,FDA-1975-N-0013,"Citizen Petition from Amuchina International, Inc.",Other,Citizen Petition,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2017-11-16T14:57:17Z,,0,0,09000064805c1daa
FDA-1977-P-0193-0002,FDA,FDA-1977-P-0193,National Food Processors Association - Supplement,Other,Supplement (SUP),2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2013-08-13T15:53:38Z,,0,0,09000064805db3dd
FDA-2009-P-0589-0003,FDA,FDA-2009-P-0589,Acknowledgement Letter to Buchanan Ingersoll & Rooney PC,Other,Acknowledgement Letter/Receipt,2009-12-16T05:00:00Z,2009,12,2009-12-16T05:00:00Z,,2013-07-27T23:02:15Z,,0,0,0900006480a69569
EPA-HQ-OPP-2009-0125-0001,EPA,EPA-HQ-OPP-2009-0125,"Public Acess for Application Containing New Active Ingredients, 2-Methyl-1 butanol and Calcium Acetate",Other,,2009-12-15T05:00:00Z,2009,12,2009-12-15T05:00:00Z,2010-01-16T04:59:59Z,2009-12-15T20:42:41Z,,0,0,0900006480a6b5ed
FDA-2009-P-0266-0005,FDA,FDA-2009-P-0266,"FDA/CDER Interim Response to Dr. Reddy's Laboratories, Inc. - Letter",Other,LET-Letter,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-08-11T01:31:24Z,,0,0,0900006480a661cd
FDA-1995-D-0298-0011,FDA,FDA-1995-D-0298,Alaska Seafood Marketing Institute - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-08-11T02:46:21Z,,0,0,09000064805998f7
FDA-2009-P-0587-0001,FDA,FDA-2009-P-0587,Buchanan Ingersoll & Rooney PC -  Citizen Petition,Other,CP-Citizen Petition,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:55Z,,0,0,0900006480a6777c
FDA-2009-P-0362-0011,FDA,FDA-2009-P-0362,Ryszard Rokicki - Supplement Citizen Petition,Other,SUP-Supplement,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:31Z,,0,0,0900006480a63846
FDA-1995-D-0298-0003,FDA,FDA-1995-D-0298,"NFPA, National Food Processors Assn. - Request for Extension Comments",Other,EXT-Request for Extension Comment Due Date,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T21:45:00Z,,0,0,09000064805998f2
FDA-1995-D-0298-0006,FDA,FDA-1995-D-0298,"FDA/CFSAN Between MaryLynn Datoc, and Robert L. Collette, and Allen W. Matthys - Memorandum of Telephone Conversations",Other,MT-Memorandum of Telephone Conversation,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T18:03:00Z,,0,0,09000064805998f9
FDA-1995-D-0298-0009,FDA,FDA-1995-D-0298,Pacific Seafood Processors Assn. - Request for Comment Due Data,Other,EXT-Request for Extension Comment Due Date,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T21:45:00Z,,0,0,09000064805998f5
FDA-2008-P-0330-0005,FDA,FDA-2008-P-0330,"FDA/CDER Response to Rakoczy Molino Mazzochi Siwik, LLP - Letter",Other,LET-Letter,2009-12-14T05:00:00Z,2009,12,,,2013-08-11T04:36:53Z,,0,0,0900006480a661d0
FDA-2009-N-0374-0016,FDA,FDA-2009-N-0374,"Ellen Frank, Director Division of Public Affairs - ""Educating the Public On the Phase-Out of Epinephrine CFC Inhalers"" [Public Workshop, September 25, 2009] - Testimony",Other,TS-Testimony,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:22Z,,0,0,0900006480a62271
FDA-2009-P-0586-0002,FDA,FDA-2009-P-0586,Acknowledgement Letter to Canada Ice Enterprises,Other,ACK-Acknowledgement Letter,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-08-11T04:36:55Z,,0,0,0900006480a67288
FDA-1981-D-0064-0003,FDA,FDA-1981-D-0064,"References for Memorandum of March 2, 1979",Other,References (External) (REF),2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2026-01-30T22:37:16Z,,0,0,0900006480a6a243
FDA-1981-D-0064-0002,FDA,FDA-1981-D-0064,Guidance - GDL,Other,GDL-Guidance,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T17:00:25Z,,0,0,0900006480a6a241
FDA-2007-P-0181-0013,FDA,FDA-2007-P-0181,"The Lillie Center, Inc. to FDA - Letter",Other,LET-Letter,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T23:01:56Z,,0,0,0900006480a67903
FDA-1995-D-0298-0013,FDA,FDA-1995-D-0298,"Ocean Beauty Seafoods, Inc. - Request fo Extension Comment Due Date",Other,EXT-Request for Extension Comment Due Date,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T19:28:24Z,,0,0,0900006480a6a5a4
FDA-1995-D-0298-0002,FDA,FDA-1995-D-0298,"National Fisheries Institute, Inc. - Request for  Extension Comment Due Data",Other,EXT-Request for Extension Comment Due Date,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-07-27T21:45:00Z,,0,0,09000064805998f1
FDA-1995-D-0298-0005,FDA,FDA-1995-D-0298,"FDA/CFSAN Between MaryLynn Datoc, and Jim Yonker and Vincent A. Curry and Kevin O'Sullivan - Memorandum of Telephone Conversations",Other,MT-Memorandum of Telephone Conversation,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T18:02:20Z,,0,0,09000064805998fa
FDA-2004-P-0279-0007,FDA,FDA-2004-P-0279,Letter from the Center for Science in the Public Interest,Other,Letter(s),2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2025-01-30T00:29:49Z,,0,0,0900006480a637bc
FDA-1995-D-0298-0007,FDA,FDA-1995-D-0298,"FDA/CFSAN to Christopher E. Rezendes, Seafood Team Leader",Other,M-Memorandum,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T18:06:30Z,,0,0,09000064805998fb
FDA-1995-D-0298-0014,FDA,FDA-1995-D-0298,Compliance Policy Guide - Guidance,Other,GDL-Guidance,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T19:32:50Z,,0,0,0900006480a6a5f9
FDA-1981-D-0064-0004,FDA,FDA-1981-D-0064,"Reference 1 - Westgate Foods - F.D.C. #57693, summarized in FDA Consumer, Oct 1. 1974- [ Background Material - BKG]",Other,BKG-Background Material,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2009-12-14T17:00:28Z,,0,0,0900006480a6a248
FDA-2009-P-0586-0001,FDA,FDA-2009-P-0586,Canada Ice Enterprises - Citizen Petition,Other,CP-Citizen Petition,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2024-11-12T04:49:03Z,,1,0,0900006480a67284
FDA-2009-P-0587-0004,FDA,FDA-2009-P-0587,Acknowledgement Letter to Buchanan Ingersoll & Rooney PC,Other,ACK-Acknowledgement Letter,2009-12-14T05:00:00Z,2009,12,2009-12-14T05:00:00Z,,2013-08-11T03:05:50Z,,0,0,0900006480a67922
FDA-2006-P-0518-0005,FDA,FDA-2006-P-0518,"George Washington University Medical Center to FDA, December 3, 2009 - Letter re FDA-2006-P-0518-0001",Other,LET-Letter,2009-12-13T05:00:00Z,2009,12,2009-12-13T05:00:00Z,,2013-07-27T23:02:07Z,,0,0,0900006480a68b1b
FDA-2008-P-0560-0005,FDA,FDA-2008-P-0560,FDA/CDER Response to Schiff & Company - Letter,Other,LET-Letter,2009-12-13T05:00:00Z,2009,12,2009-12-13T05:00:00Z,,2013-07-27T23:01:53Z,,0,0,0900006480a6714e
FDA-2009-Q-0301-0013,FDA,FDA-2009-Q-0301,Cover Letter from Nestle Nutrition to FDA/CFSAN - Cover Letter for Redacted Supporting Materials of Qualified Health Claim Petition  - Qualified Health Claim Petition] re FDA-2009-Q-0301-0002,Other,LET-Letter,2009-12-11T05:00:00Z,2009,12,2009-12-11T05:00:00Z,,2013-08-11T03:05:52Z,,0,0,0900006480a69264
FDA-2009-P-0471-0007,FDA,FDA-2009-P-0471,"Mark Antell, et al - Supplement",Other,SUP-Supplement,2009-12-11T05:00:00Z,2009,12,2009-12-11T05:00:00Z,,2013-07-27T23:00:42Z,,0,0,0900006480a5dd84
FDA-2004-P-0278-0007,FDA,FDA-2004-P-0278,Center for Science in the Public Interest to FDA - Letter,Other,LET-Letter,2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,,2025-02-19T16:43:59Z,,0,0,0900006480a6305a
FDA-1998-D-0025-0037,FDA,FDA-1998-D-0025,Guidance on Pet Drugs --- Current Good Manufacturing Practice (CGMP) - GDL,Other,GDL-Guidance (Supporting and Related Materials),2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,,2024-11-07T22:11:10Z,,1,0,0900006480a686eb
FDA-1977-N-0049-0002,FDA,FDA-1977-N-0049,"Internal Memorandum from William E. Gilbertson (HFD-210) to Dockets Management Branch (HFA-305) December 24, 1991",Other,Memorandum,2009-12-10T05:00:00Z,2009,12,2009-12-10T05:00:00Z,,2019-02-07T14:57:56Z,,0,0,0900006480a68e9d
FDA-1995-S-0039-0224,FDA,FDA-1995-S-0039,NDI 586 -  Oxaloacetic Acid from Terra Biological LLC,Other,75 Day PreMarket Notification,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2016-09-30T14:23:36Z,,0,0,0900006480a2eb6f
FDA-2009-P-0558-0003,FDA,FDA-2009-P-0558,"Lachman Consultant Services, Inc. - Withdrawal",Other,WDL-Withdrawal,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-08-11T04:36:50Z,,0,0,0900006480a63464
FDA-2008-P-0542-0008,FDA,FDA-2008-P-0542,FDA/CFSAN Response to Coburn & Coffman PLLC - Petition Denial,Other,PDN-Petition Denial,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-07-27T23:01:55Z,,0,0,0900006480a67862
FDA-1995-S-0039-0233,FDA,FDA-1995-S-0039,Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 305 -  Extract of Garcinia Cambogia (Burren Spring Trim),Other,Supplement (SUP),2009-12-09T05:00:00Z,2009,12,,,2016-09-30T14:23:38Z,,0,0,0900006480a6272c
FDA-1995-S-0039-0230,FDA,FDA-1995-S-0039,"NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness",Other,75 Day PreMarket Notification,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2016-09-30T14:23:37Z,,0,0,0900006480a2bc6d
FDA-2009-P-0581-0015,FDA,FDA-2009-P-0581,"Acknowledgement Letter to Bayer HealthCare LLC (Ropes & Gray, LLP)",Other,ACK-Acknowledgement Letter,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-08-11T04:36:50Z,,0,0,0900006480a6357c
FDA-1995-S-0039-0232,FDA,FDA-1995-S-0039,Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 304 - Extract of Garcinia Cambogia (Coolwater Trim),Other,Supplement (SUP),2009-12-09T05:00:00Z,2009,12,,,2016-09-30T14:23:38Z,,0,0,0900006480a6272b
FDA-2009-P-0259-0003,FDA,FDA-2009-P-0259,"FDA/CDER Interim Response to Akorn, Inc. - Letter",Other,LET-Letter,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-08-11T01:31:21Z,,0,0,0900006480a62241
FDA-2009-P-0581-0001,FDA,FDA-2009-P-0581,"Bayer HealthCare LLC (Ropes & Gray, LLP) - Citizen Petition",Other,CP-Citizen Petition,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-12-08T02:21:43Z,,0,0,0900006480a63509
FDA-2020-D-1381-0001,FDA,FDA-2020-D-1381,Guidance PET Drugs — Current Good Manufacturing Practice (CGMP),Other,Guidance,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2024-11-06T23:36:02Z,,1,0,09000064845e6c9d
FDA-2009-E-0175-0008,FDA,FDA-2009-E-0175,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-12-08T05:00:00Z,2009,12,2009-12-08T05:00:00Z,,2013-07-27T23:01:42Z,,0,0,0900006480a666a0
FDA-1984-P-0033-0016,FDA,FDA-1984-P-0033,"FDA/CDER and Upjohn Company, March 21, 1984 - Memorandum of Telephone Conversation",Other,MT-Memorandum of Telephone Conversation,2009-12-08T05:00:00Z,2009,12,,,2013-07-27T21:48:42Z,,0,0,09000064805a8227